Johannes Grillari,Regina Grillari,Matthias Hackl,Sylvia Weilner
申请号：
US16060919
公开号：
US20180363061A1
申请日:
2016.12.12
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention relates to the therapy, prophylaxis and diagnosis of disorders that are associated with aberrant bone mineral density, in particular osteoporosis； wherein the level of selected microRNAs in samples of patients are detected and wherein an increase or decrease of said level compared to the level of healthy indivduals is indicative of the disorder.
